Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 3/20 | 0.35 |
| ▸ | RAB9A | P51151 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14282584 | 0.91 | AKR1C3 (0.44) | AKR1C3LMNAALDH1A1SRD5A2CES2 | |
| SCHEMBL8986306 | 0.86 | AKR1C3 (0.40) | AKR1C3LMNAALDH1A1SRD5A2CES2 | |
| SCHEMBL13328292 | 0.84 | ALDH1A1 (0.47) | AKR1C3LMNAALDH1A1SRD5A2CES2 | |
| SCHEMBL13638717 | 0.84 | AKR1C3 (0.38) | AKR1C3LMNAALDH1A1SRD5A2CES2 | |
| SCHEMBL11922326 | 0.84 | AKR1C3 (0.38) | AKR1C3LMNAALDH1A1SRD5A2CES2 | |
| SCHEMBL8986301 | 0.84 | AKR1C3 (0.38) | AKR1C3LMNAALDH1A1SRD5A2CES2 | |
| SCHEMBL13592741 | 0.83 | LMNA (0.34) | AKR1C3LMNAALDH1A1SRD5A2NPC1 | |
| SCHEMBL10108773 | 0.81 | NPC1 (0.31) | NPC1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL13593066 | 0.80 | NPC1 (0.39) | AKR1C3LMNAALDH1A1SRD5A2CES2 | |
| SCHEMBL8986302 | 0.79 | MEN1 (0.36) | AKR1C3LMNAALDH1A1SRD5A2CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8304561-B2 | Synthetic route to ABCD-porphyrins | NORTH CAROLINA STATE UNIVERSITY (US) | 2012-11-06 | — | — | US | disclosed |
| US-20120209009-A1 | SYNTHETIC ROUTE TO ABCD-PORPHYRINS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-08-16 | — | — | US | disclosed |
| US-20120209009-A1 | SYNTHETIC ROUTE TO ABCD-PORPHYRINS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-08-16 | — | — | US | disclosed |
| US-8188298-B2 | Synthetic route to ABCD-porphyrins | NORTH CAROLINA STATE UNIVERSITY (US) | 2012-05-29 | — | — | US | disclosed |
| US-8188298-B2 | Synthetic route to ABCD-porphyrins | NORTH CAROLINA STATE UNIVERSITY (US) | 2012-05-29 | — | — | US | disclosed |
| US-20110306774-A1 | SYNTHETIC ROUTE TO ABCD-PORPHYRINS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-12-15 | — | — | US | disclosed |
| US-20110306774-A1 | SYNTHETIC ROUTE TO ABCD-PORPHYRINS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-12-15 | — | — | US | disclosed |
| US-7994312-B2 | Synthetic route to ABCD-porphyrins | NORTH CAROLINA STATE UNIVERSITY (US) | 2011-08-09 | — | — | US | disclosed |
| US-7994312-B2 | Synthetic route to ABCD-porphyrins | NORTH CAROLINA STATE UNIVERSITY (US) | 2011-08-09 | — | — | US | disclosed |
| US-7595407-B2 | Boron complexation strategy for use in manipulating 1-acyldipyrromethanes | NORTH CAROLINA STATE UNIVERSITY (US) | 2009-09-29 | — | — | US | disclosed |
| US-20080027232-A1 | BORON COMPLEXATION STRATEGY FOR USE IN MANIPULATING 1-ACYLDIPYRROMETHANES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-01-31 | — | — | US | disclosed |
| US-20080027232-A1 | BORON COMPLEXATION STRATEGY FOR USE IN MANIPULATING 1-ACYLDIPYRROMETHANES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-01-31 | — | — | US | disclosed |
| US-7323561-B2 | Metal complexation of 1-acyldipyrromethanes and porphyrins formed therefrom | NORTH CAROLINA STATE UNIVERSITY (US) | 2008-01-29 | — | — | US | disclosed |
| US-7323561-B2 | Metal complexation of 1-acyldipyrromethanes and porphyrins formed therefrom | NORTH CAROLINA STATE UNIVERSITY (US) | 2008-01-29 | — | — | US | disclosed |
| US-7317108-B2 | Boron complexation strategy for use in manipulating 1-acyldipyrromethanes | NORTH CAROLINA STATE UNIVERSITY (US) | 2008-01-08 | — | — | US | disclosed |
| US-7317108-B2 | Boron complexation strategy for use in manipulating 1-acyldipyrromethanes | NORTH CAROLINA STATE UNIVERSITY (US) | 2008-01-08 | — | — | US | disclosed |
| US-7282582-B2 | Boron complexation strategy for use in manipulating 1-acyldipyrromethanes | NORTH CAROLINA STATE UNIVERSITY (US) | 2007-10-16 | — | — | US | disclosed |
| US-7282582-B2 | Boron complexation strategy for use in manipulating 1-acyldipyrromethanes | NORTH CAROLINA STATE UNIVERSITY (US) | 2007-10-16 | — | — | US | disclosed |
| US-20070088158-A1 | BORON COMPLEXATION STRATEGY FOR USE IN MANIPULATING 1-ACYLDIPYRROMETHANES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-04-19 | — | — | US | disclosed |
| US-20070088158-A1 | BORON COMPLEXATION STRATEGY FOR USE IN MANIPULATING 1-ACYLDIPYRROMETHANES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070088158-A1 | BORON COMPLEXATION STRATEGY FOR USE IN MANIPULATING 1-ACYLDIPYRROMETHANES | DECR2, ANTXR2, CD79B | AKR1C3 341/4885LMNA 4136/4885ALDH1A1 2207/4885 |
| US-20120209009-A1 | SYNTHETIC ROUTE TO ABCD-PORPHYRINS | ABCB7, ALAD, SLC39A14 | AKR1C3 1386/4885LMNA 4635/4885ALDH1A1 1829/4885 |
| US-20110306774-A1 | SYNTHETIC ROUTE TO ABCD-PORPHYRINS | ABCB7, ALAD, SLC39A14 | AKR1C3 1386/4885LMNA 4635/4885ALDH1A1 1829/4885 |
| US-20080027232-A1 | BORON COMPLEXATION STRATEGY FOR USE IN MANIPULATING 1-ACYLDIPYRROMETHANES | DECR2, ANTXR2, CD79B | AKR1C3 341/4885LMNA 4136/4885ALDH1A1 2207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.